研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

女性乳腺癌激素受体状态的预测模型不适用于男性:乳腺癌性别差异的进一步证据。

Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer.

发表日期:2023 Nov 08
作者: Subarnarekha Chatterji, Jan Moritz Niehues, Marko van Treeck, Chiara Maria Lavinia Loeffler, Oliver Lester Saldanha, Gregory Patrick Veldhuizen, Didem Cifci, Zunamys Itzell Carrero, Rasha Abu-Eid, Valerie Speirs, Jakob Nikolas Kather
来源: npj Breast Cancer

摘要:

男性和女性乳腺癌的预后和治疗都依赖于雌激素受体 α (ERα) 和孕激素受体 (PR) 的表达来指导治疗。此前的研究表明,乳腺癌中ERα和PR存在性别特异性结合特征,与直觉相反的是,ERα表达在男性乳腺癌中比女性乳腺癌中更常见。我们假设这些差异可能具有人类观察者无法察觉的形态表现,但可以通过计算来阐明。为了研究这一点,我们使用 H 训练了针对 ERα 和 PR 的基于注意力的多实例学习预测模型
Breast cancer prognosis and management for both men and women are reliant upon estrogen receptor alpha (ERα) and progesterone receptor (PR) expression to inform therapy. Previous studies have shown that there are sex-specific binding characteristics of ERα and PR in breast cancer and, counterintuitively, ERα expression is more common in male than female breast cancer. We hypothesized that these differences could have morphological manifestations that are undetectable to human observers but could be elucidated computationally. To investigate this, we trained attention-based multiple instance learning prediction models for ERα and PR using H&E-stained images of female breast cancer from the Cancer Genome Atlas (TCGA) (n = 1085) and deployed them on external female (n = 192) and male breast cancer images (n = 245). Both targets were predicted in the internal (AUROC for ERα prediction: 0.86 ± 0.02, p < 0.001; AUROC for PR prediction = 0.76 ± 0.03, p < 0.001) and external female cohorts (AUROC for ERα prediction: 0.78 ± 0.03, p < 0.001; AUROC for PR prediction = 0.80 ± 0.04, p < 0.001) but not the male cohort (AUROC for ERα prediction: 0.66 ± 0.14, p = 0.43; AUROC for PR prediction = 0.63 ± 0.04, p = 0.05). This suggests that subtle morphological differences invisible upon visual inspection may exist between the sexes, supporting previous immunohistochemical, genomic, and transcriptomic analyses.© 2023. The Author(s).